IMMUNO CLINICAL TRIAL FOR RECTAL CANCER, **before surgery**, at MD Anderson:
the possibility of receive an IMMUNOTHERAPY just at the start of treatment.
Talimogene Laherparepvec [T-VEC, Imlygic, immunotherapy approved for melanoma, given as injection to the tumour ]Capecitabine, and Chemoradiation Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer NCT03300544
Rectal Adenocarcinoma
Stage III Rectal Cancer AJCC v7
Stage IIIA Rectal Cancer AJCC v7
Stage IIIB Rectal Cancer AJCC v7
Stage IIIC Rectal Cancer AJCC v7
Stage IV Rectal Cancer AJCC v7
Stage IVA Rectal Cancer AJCC v7
Stage IVB Rectal Cancer AJCC v7
https://clinicaltrials.gov/ct2/show/NCT03300544